Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal

por Aragão, Filipa, Vera, José, Vaz Pinto, Inês
Publicado 2012

Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment

por Fagiuoli, Stefano, Ruggeri, Matteo, Aragao, Filipa, Blissett, Rob
Publicado 2021

An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine

por Rogatto, Felipe, Bouee, Stephane, Jeanbat, Vivianne, Piontkowsky, David, Aragao, Filipa, Bosse, Matthew
Publicado 2014

Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Stud...

por Ruggeri, Matteo, Signorini, Alessandro, Caravaggio, Silvia, Rua, João, Luís, Nuno, Braz, Sandra, Aragão, Filipa
Publicado 2022

Time-dependent endpoints as predictors of overall survival in multiple myeloma

por Félix, Jorge, Aragão, Filipa, Almeida, João M, Calado, Frederico JM, Ferreira, Diana, Parreira, António BS, Rodrigues, Ricardo, Rijo, João FR
Publicado 2013

Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study

por Serrano-Villar, Sergio, Cohen, Calvin, Baker, Jason V., Janeiro, Maria João, Aragão, Filipa, Melbourne, Kathleen, Gonzalez, Jose Luis, Lara, Laura, Kim, Connie, Moreno, Santiago
Publicado 2022

Corrigendum: Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling...

por Serrano-Villar, Sergio, Cohen, Calvin, Baker, Jason V., Janeiro, Maria João, Aragão, Filipa, Melbourne, Kathleen, Gonzalez, Jose Luis, Lara, Laura, Kim, Connie, Moreno, Santiago
Publicado 2023

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression

por Castillo-Mancilla, Jose R, Morrow, Mary, Hunt, Peter W, Schnittman, Samuel R, Phillips, Andrew N, Baker, Jason V, Haberer, Jessica E, Janeiro, Maria Joao, Aragao, Filipa, Cohen, Cal, Musinguzi, Nicholas, Brown, Todd T, Cavassini, Matthias, Glass, Tracy R, Serrano-Villar, Sergio, Mawhinney, Samantha, Siedner, Mark
Publicado 2023

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-...

por Teira, Ramón, Diaz-Cuervo, Helena, Aragão, Filipa, Castaño, Manuel, Romero, Alberto, Roca, Bernardino, Montero, Marta, Galindo, Maria José, Muñoz-Sánchez, Maria Jose, Espinosa, Nuria, Peraire, Joaquim, Martínez, Elisa, de la Fuente, Belén, Domingo, Pere, Deig, Elisabeth, Merino, María Dolores, Geijo, Paloma, Estrada, Vicente, Sepúlveda, María Antonia, García, Josefina, Berenguer, Juan, Currán, Adriá
Publicado 2022

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV

por Teira, Ramón, Diaz-Cuervo, Helena, Aragão, Filipa, Marguet, Sophie, de la Fuente, Belén, Muñoz, Maria Jose, Abdulghani, Nadia, Ribera, Esteban, Domingo, Pere, Deig, Elisabeth, Peraire, Joaquim, Roca, Bernardino, Montero, Marta, Galindo, Maria José, Romero, Alberto, Espinosa, Nuria, Lozano, Fernando, Merino, María Dolores, Martínez, Elisa, Geijo, Paloma, Estrada, Vicente, García, Josefina, Sepúlveda, M. Antonia, Berenguer, Juan
Publicado 2021